Find investors
← Back to all investors
Colin North
ResearchedAngel Investors

Colin North

Analyst

Angel InvestorsSeed Round
Pitch Colin

Get their honest, personalized take on your startup.

Sign in to pitch Colin

At a glance

Full Name
Colin J. North
Title
Associate Director (previously Senior Associate / Analyst-Associate at Shore Capital Partners)
Firm
Peninsula Capital Partners, L.L.C. (previously Shore Capital Partners)
Firm Type
Private equity / junior capital — lower-middle-market. (Note: the stub's "Angel Investor" label is not supported; both firms in his career are institutional PE, not angel/seed.)
Investment Stage
Middle-market buyouts, recapitalizations, and independent-sponsor transactions (mezzanine debt and equity) — not seed/angel
Check Size
At Peninsula: $5M–$40M for mezzanine commitments; $2M–$20M for equity investments (firm-level criteria)
Target Company Profile
Middle-market companies with ~$3M+ EBITDA and roughly $10M–$100M in revenue; non-sponsored and independently sponsored deals
Sector Focus
Generalist across healthcare, food & beverage, business services, and industrials (sectors he covered at Shore Capital)
Geographic Focus
United States / North America
Location
Southfield / Metro Detroit, Michigan (previously Chicago, Illinois)

Background

Colin North is an Associate Director at Peninsula Capital Partners, a Detroit-area private equity firm founded in 1995 that provides customized "junior capital" — subordinated debt, preferred stock, and equity — to middle-market companies in management buyouts, leveraged recapitalizations, and independent-sponsor transactions. Peninsula has raised roughly $2.4 billion across eight funds and invested about $2.1 billion into 150-plus portfolio platforms since its founding.

Before Peninsula, North spent about six years at Shore Capital Partners, the Chicago-based (with a Nashville office) lower-middle-market/microcap private equity firm known for building healthcare and multi-industry platforms. He joined Shore as an intern in 2017 and came on full-time in 2018, working on dozens of transactions across healthcare, food & beverage, business services, and industrial sectors. His work there centered on identifying and diligencing acquisition targets, supporting portfolio-company initiatives, and assisting with special projects — the analyst/associate-level deal work that the original stub reflects (his [hidden] email and 312 area-code phone date from this period).

North earned a BS from the University of Notre Dame. Outside of work he lists spending time with his family and dog, traveling to Northern Michigan, and following Detroit sports.

Because his career to date has been in institutional private equity (control and structured-capital investing), the stub's characterization of him as an "Angel Investor" writing "Seed Round" checks does not match the verifiable record and appears to be a mis-tag.

Investment Thesis & Focus

  • Invests through Peninsula's flexible-capital mandate: mezzanine/junior debt and equity in middle-market companies, as either a control or non-control (minority) investor.
  • Deal types: independent-sponsor deals, management buyouts, and leveraged recapitalizations — i.e., established, cash-flowing businesses rather than early-stage startups.
  • Firm check sizes: ~$5M–$40M mezzanine; ~$2M–$20M equity.
  • Company profile Peninsula backs: businesses with at least ~$3M EBITDA and roughly $10M–$100M revenue, to whom the firm offers operational, strategic, and financial guidance alongside capital.
  • Sector fluency built at Shore Capital across healthcare, food & beverage, business services, and industrials — a generalist, multi-industry lower-middle-market lens.

Notable Investments

  • Shore Capital Partners — where North did his early deal work — is a prolific microcap platform builder concentrated in healthcare services, plus food & beverage, business services, and industrials; he contributed to "dozens of transactions" during his six years there.
  • Peninsula Capital Partners — his current firm — has invested in 150+ middle-market platform companies since 1995 via its eight funds, providing junior capital to non-sponsored and independently sponsored deals.
  • (No specific portfolio company can be reliably tied to North by name from public sources; treat firm portfolios rather than personal attributions as the record here.)

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.